Train harder · Free ship $75+ · Gear up now
Login Register
glp 1 and sglt2

glp 1 and sglt2 Combining GLP-1 Receptor Agonists Inhibitors in Type 2 Diabetes Mellitus: A Scoping Review and Expert Insights for Clinical Practice Utilizing the Nominal Group Technique SGLT2 Inhibitors vs. GLP-1 Agonists

SKU: 44489266638

4.8
EUR25.47 EUR61.47

Pay in 4 interest-free payments of $6.37 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Description

Gasbjerg LS, Hartmann B, Christensen MB, et al

glp 1 and sglt2 Combining GLP-1 Receptor Agonists Inhibitors in Type 2 Diabetes Mellitus: A Scoping Review and Expert Insights for Clinical Practice Utilizing the Nominal Group Technique SGLT2 Inhibitors vs. GLP-1 Agonists

For instance, exendin-4 has been shown to ameliorate the high glucose-induced fibronectin (FN) and type I collagen (Col1) expression in tubular epithelial cells by inhibiting the secretion of miR-192, an microRNA (miRNA) that is regulated by p53 and plays a role in renal fibrosis (Yin et al., 2018)

glp 1 and sglt2 Combining GLP-1 Receptor Agonists Inhibitors in Type 2 Diabetes Mellitus: A Scoping Review and Expert Insights for Clinical Practice Utilizing the Nominal Group Technique SGLT2 Inhibitors vs. GLP-1 Agonists

[00:32:01] Emily Field: As we zoom out and look at this whole conversation, I think theres an important reframe thats worth making

glp 1 and sglt2 Combining GLP-1 Receptor Agonists Inhibitors in Type 2 Diabetes Mellitus: A Scoping Review and Expert Insights for Clinical Practice Utilizing the Nominal Group Technique SGLT2 Inhibitors vs. GLP-1 Agonists

Provides sodium, potassium, calcium, magnesium, and collagen in a warm, easy-to-consume format

glp 1 and sglt2 Combining GLP-1 Receptor Agonists Inhibitors in Type 2 Diabetes Mellitus: A Scoping Review and Expert Insights for Clinical Practice Utilizing the Nominal Group Technique SGLT2 Inhibitors vs. GLP-1 Agonists

doi:10.1038/npjamd.2016.3 33

glp 1 and sglt2 Combining GLP-1 Receptor Agonists Inhibitors in Type 2 Diabetes Mellitus: A Scoping Review and Expert Insights for Clinical Practice Utilizing the Nominal Group Technique SGLT2 Inhibitors vs. GLP-1 Agonists
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products